Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Delivra Health Brands reports rise in full-year net revenue

"Our fiscal year-end financial results illustrate the successful strategic repositioning of the company to a health and wellness company, successfully restructuring our internal and external teams to increase revenues, operating margins and

Delivra Health Brands Inc. (TSX-V:DHB) - formerly known as Harvest One Cannabis Inc - has said its net revenue for the year ended June 30 rose by 2.3% from the previous year to $8.14 million, driven by higher sales in the company's US operations.

"Our fiscal year-end financial results illustrate the successful strategic repositioning of the company to a health and wellness company, successfully restructuring our internal and external teams to increase revenues, operating margins and profitability," Gord Davey, the company's president and CEO of Delivra Health said in a statement.

"The past year has been challenging given increasing inflation, supply chain disruptions and slower activity in capital markets. Throughout the year, management has focused on the execution of customer-specific programs, expanding e-commerce platforms, launching innovation products and improving distribution in international markets. In the coming fiscal year, we expect to continue to increase our revenues and profitability through a combined focus on US, international and eCommerce markets," he added.

READ: Delivra Health Brands confirms name change from Harvest One

Delivra Health reported gross profit of $2.60 million and a gross profit margin of 32% in fiscal 2022 compared with $1.91 million and a gross profit margin of 24% from continued operations in fiscal 2021. This increase was due to operational improvements, cost alignment projects and the reduction in financial inventory write-downs, it said.

The company reported EBITDA (earnings before interest, taxes, depreciation and amortization) of negative $2.76 million in fiscal 2022, compared with negative $6.06 million in fiscal 2021, representing a $3.3million or 33% year-over-year improvement, driven by management's efforts in focusing on margin improvement supported by efficient administrative and selling support functions.

Delivra Health helps people take control of their health with alternative wellness solutions. The Delivra Health portfolio features innovative brands like Dream Water and LivRelief, which deliver relief from common everyday issues like chronic pain, anxiety and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy and, in turn, quality of life.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK